Use of a gonadotropin-releasing hormone antagonist for endometrial maturation and synchronization in an ovum recipient

In: Fertility and Sterility · 2003 · vol. 80(6) , pp. 1508–1509 · doi:10.1016/s0015-0282(03)02203-9 · PMID:14667892 · W1976995013
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-14

This study investigated the efficacy of a GnRH antagonist in synchronizing endometrial maturation for ovum recipients undergoing embryo transfer.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo report the novel use of hMG and the GnRH antagonist for endometrial preparation and synchronization in a woman participating in an ovum donation program who was resistant to endometrial preparation with estrogen replacement.DesignCase report.SettingTertiary fertility center.Patient(s)The patient had inadequate endometrial maturation, as determined by pelvic ultrasound (thickness of <5 mm), after estrogen replacement. Ovarian hyperstimulation with hMG and a GnRH antagonist resulted in an endometrial thickness of 7.5 mm. Synchronization with a ovum donor resulted in a delivered twin gestation.Intervention(s): Late follicular transvaginal ultrasound.Main outcome measure(s)Appropriate endometrial maturation and pregnancy.Result(s)Appropriate endometrial maturation.Conclusion(s)For women with inadequate endometrial maturation with simple estrogen replacement, ovarian hyperstimulation with hMG and a GnRH antagonist can yield appropriate endometrial maturation for pregnancy through ovum donation.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (4)

Source provenance

openalex
last seen: 2026-05-11T06:09:19.794676+00:00
unpaywall
last seen: 2026-08-19T06:23:00.919175+00:00
License: CC0 · commercial use OK